Califf Says US FDA Ready If Human Avian Flu Infections Jump

The FDA commissioner said an H5N1 vaccine can be developed from the same mRNA platform used to create the COVID-19 vaccines, but funds are needed to ensure production can begin quickly if a human outbreak occurs.

Robert Califf
FDA Commissioner Robert Califf spoke to Senators about the FDA's avian flu response during a hearing on the agency's FY 2025 budget request. • Source: Screenshot of Senate broadcast

More from Legislation

More from Pink Sheet